CD19 and mantle cell lymphoma: Subsequently, Mathur et al. identified Wnt signaling as a critical oncogenic pathway activated in MCL CD19-/CD45+ CSCs cells (also called MCL-initiating cells or MCL-IC cells) and associated with ibrutinib resistance [46].